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Studies of the various kinds of immunoglobulin (Ig)  allotype and isotype suppres- 
sions induced by perinatal exposure to anti-Ig antibodies have yielded many valuable 
insights into the normal processes that control B cell differentiation and expression. 
For  example,  the  demonstration  that  exposure  to  antibodies  to  an  IgG  isotype 
specifically suppresses production of that isotype, whereas the exposure to antibodies 
to IgM suppresses production of IgM and all IgG isotypes provided the first outlines 
of the  precursor-progeny relationships  in  the  B  cell  development  pathway  (1,  2). 
Similarly, the proof that suppressor T  cells regulate antibody production rests in part 
on the highly specific suppression of allotype-marked adoptive secondary antibody 
responses  demonstrable  with  suppressor  T  cells  induced  by  perinatal  exposure to 
antiallotype antibodies  (3,  4).  Thus,  although  the mechanisms  responsible for sup- 
pression induction during the neonatal period are of interest per se, the properties of 
the suppressions  induced by different kinds of antibody exposures frequently offer 
more broadly applicable information. 
At least three characteristic patterns of allotype suppression have been described in 
allotype heterozygotes exposed to antibodies reactive with paternal  Ig allotypes. In 
rabbits, the antibodies commonly used for suppression induction react with Ig light 
chain or Ig heavy chain variable-region determinants present on most of the Ig in 
serum in homozygotes and a  little less than one-half the serum Ig in heterozygotes. 
After perinatal antiallotype exposure, B cells bearing the target allotype are depleted 
and  gradually recover. Paternal  allotype levels in serum  remain low well after the 
allotype-bearing  B  cells  return;  however,  older  suppressed  animals  (>6-mo-old) 
usually initiate and maintain substantial serum allotype production. In general, the 
suppression  of paternal  allotype  production  is  accompanied  by  a  compensatory 
increase in maternal serum-allotype levels that return to normal when suppression is 
relieved (5-8). 
In  the  mouse,  antiallotype  antibodies  almost  exclusively detect  Ig  heavy chain 
constant-region  determinants  and  thus  are  restricted  to  reaction  with  allotypes 
represented on one or occasionally two Ig isotypes (9).  The suppression induced by 
these antiallotype antibodies appears similar to the suppression induced by heterolo- 
gous anti-isotype antibodies except that production of only one of the two allotypes 
in the heterozygote is affected (1, 2,  10-12). 
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Anti-Ig-induced suppression persists for a much shorter time in most mouse strains 
than it does in rabbits (8-12 wk); however, a long-term ("chronic") allotype suppres- 
sion  that  differs from the  usual  allotype suppression  obtained  in  either mouse or 
rabbit can be induced in genetically susceptible mice such as the (BALB/c ×  SJL)F1 
hybrid (BALB/c mother, SJL father). This suppression shows a characteristic biphasic 
pattern, persisting initially for about as long as the "short-term" suppression in other 
mouse  strains  and  hybrids,  abating  for several  weeks,  and  then  returning  to  full 
strength when the animals reach 20-24  wk of age to completely suppress  paternal 
allotype production thereafter. Maternal allotype production in the suppressed ani- 
mals (of either type) remains comparable to controls, i.e., compensatory increases in 
maternal allotype serum levels do not occur (10,  13-15). 
Short-term and chronic suppression are also distinguished by the breadth of their 
affect on IgG production.  Short-term suppression can be induced for the paternal 
allotype represented in any IgG isotype. Chronic suppression, in contrast, has been 
induced thus far only for IgG2a allotypes and is more effective when induced for the 
paternal Igh-lb (SJL-derived) allotype in BALB/c × SJL than for the Igh-la (BALB/ 
c-derived) paternal allotype in reciprocal hybrids (10). The allotype suppressor T cells 
used in the studies mentioned above (3, 4)  were derived from 6-mo-old BALB/c × 
SJL  hybrids  in  which  Igh-lb  (lb)  allotype  production  is  chronically suppressed 
because of perinatal exposure to maternal anti-lb antibodies. 
Studies presented here describe a  new kind of allotype suppression that occurs in 
mice but behaves more like the suppression  described in rabbits.  This suppression, 
induced by injecting neonatal BALB/c ×  SJL mice with monoclonal antibody to the 
paternal  IgD allotype (Igh-5b),  differs markedly from either chronic or short-term 
suppression. Igh-5b-bearing (5b+) cells are depleted from the neonate and gradually 
recover over the first several months of the animal's life. Production of paternal IgG 
allotypes is drastically (but not completely) reduced until the animals reach ~24 wk 
of age, after which it accelerates and the animals soon achieve and maintain normal 
serum levels of the paternal allotypes; and, in contrast with other forms of allotype 
suppression  in  the  mouse,  maternal  IgG  allotype  serum  levels  show  a  clear-cut 
compensatory increase during the period of paternal allotype suppression induced by 
anti-5b exposure. 
We have shown previously (11) that perinatal exposure to antibodies to IgM (6b) 
allotypic determinants usually present on the same cells as the IgD (5b) determinants 
induces suppression for IgG allotype production in BALB/c ×  SJL animals; however, 
in contrast with anti-5b, the anti-6b antibodies induce a  suppression whose charac- 
teristics essentially correspond to the chronic form of allotype suppression induced by 
perinatal  exposure  to  conventional or  monoclonal anti-lb  antibodies  (injected or 
maternally  transmitted).  For  example,  anti-6b-exposed  animals  show  the  typical 
failure to produce lb after 6 mo of age (11). This chronic suppression can be induced 
for either parental IgG2a allotype by exposure of reciprocal hybrid mice to maternal 
antibodies to the paternal IgM allotype and can be induced for both parental IgG2a 
allotypes  in  either  hybrid  by  exposure  to  heterologous  (goat)  anti-IgM  isotype 
antibodies.  Thus,  although  the  allotype specificity of the  suppression  induced by 
either anti-5b or anti-6b suggests that suppression results from reaction of the inducing 
antibody with  Ig on  the  "haplotype-committed" precursors  of lb-producing cells, 
these two antibodies induce qualitatively different types of suppression. TOKUHISA ET AL.  923 
TABLE  I 
Monoclonat Antibodies and Myeloma Proteins Used in These Studies 
Use  Antibody  Name  Characterization*  Label 
specificity  species/isot  ype/allotype 
Suppression induction  Igh-5b (IgD allo)  Igh(5b)6.3  Mouse IgGl  Igh-4a 
Suppression induction  Igh-lb (IgGz~  allo)  Igh(lb)2.9  Mouse IgG2. Igh-la 
RIA  Igh-la (IgG~ allo)  Igh(la)8.3  Mouse IgG~ Igh-lb 
RIA  Igh-lb (IgG~ allo)  Igh(lb)5.7  Mouse IgGa 
RIA  Igh-4a (IgG1  allo)  Igh (4a) 10.9  Mouse IgG2, Igh- 1  b 
RIA  Igh-4b (IgG~  allo)  Igh(4h) 12.8  Mouse !gG~  Igh-4a 
12s  1 
125  I 
z25  I 
1251 
RIA standard  Myeloma protein  GPC-8  Mouse IgG2. Igh-la 
RIA standard  Myeloma protein  C.BPC- 101  Mouse IgG~ Igh- lb 
RIA standard  Myeloma protein  MOPC-21  Mouse IgGl  Igh-4a 
RIA standard  Myeloma protein  MOPC-245T  Mouse  IgGl  Igh-4b 
FACS analysis  Igh-5a (IgD allo)  Igh(5a)7.2  Mouse IgG2a Igh-lb  FITC 
FACS analysis  Igh-5b (IgD allo)  H 6/31  Mouse IgM  Igh-6a  FITC 
FACS analysis  ThB (splenic B)  53-9.2  Rat  IgG2c  FITC 
FACS analysis  IgM  151-I 19  Rat  IgG~  FITC 
Depletion of T cells 
from spleen cell sus- 
pensions 
Thy- 1.2  30-H 12  Rat  IgG2b 
* Isotype/allotype correspondence: IgM, Igh-6; IgD, Igh-5; IgG3, no known allotypes; I  ,gGb~  , Igh-4; IgG2b, 
Igh-3; IgG2a, Igh-1. BALB/c carries Igh  allotypes, e.g., Igh-la; C57BL/10 carries Igh  allotypes, e.g., 
Igh- lb. 
This  distinction,  which  introduces  a  fascinating complexity into  the  mechanisms 
responsible for suppression induction, raises some intriguing questions about precur- 
sor-progeny relationships  among the neonatal B cell populations that carry only IgM 
and  those  that  carry both  IgM  and  IgD and  the  potential  role(s)  that  such  B  cell 
populations play in establishing favorable conditions for persistent IgG production in 
adult animals. 
Materials  and Methods 
Mice.  (BALB/c  X  SJL)F~  mice  raised  in  our  colony  (Genetics  Department,  Stanford 
University Stanford, Calif.)  were used for these studies. 
Antibodies.  A wide variety ofmonoclonal antibodies and myeloma proteins were used (Table 
I). With one exception, H6/31, (kindly supplied by Dr. Terry Pearson and Dr. Cesar Milstein, 
Medical  Research  Council,  Cambridge,  England)  all  of the  monoclonal  antibodies  were 
produced  and  characterized  in  our  laboratory  by Dr. J.  Ledbetter,  Dr.  V.  Oi,  Dr.  L.  A. 
Herzenberg, and co-workers, Stanford University (16, 17). 
Neonatal Antibody Exposures.  Anti-5b-exposed mice were injected intraperitoneally with 250 
#g of purified  monoclonal antibody between  4  and  7 d  of age.  Anti-1b-exposed mice were 
exposed to maternally transmitted antibody, as previously described (10), or were injected with 
250 #g of purified monoclonal anti-lb (2.9) intraperitoneally between 4 and 7 d of age (18). 
Antigenic  Exposures.  For in situ  responses and  memory B cell  priming, mice were injected 
intraperitoneally with  100 pg of DNP-KLH (2,4-dinitrophenyl hapten conjugated to keyhole 
limpet  hemocyanin;  I  Pacific  Bio-Marine  Laboratories  Inc.,  Venice,  Calif.).  For  "carrier" 
1  Abbreviations used in  this paper:  DNP-KLH,  2,4-dinitrophenyl hapten  conjugated  to keyhole limpet 
hemocyanin; FACS, fluorescence-activated cell sorter; FITC,  fluorescein isothiocyanate; RIA, radioim- 
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priming, mice were injected with  100 #g of KLH. All antigens were injected intraperitoneally 
as alum precipitates  together with  2.2  ×  10  x° eells/ml  of killed  Bordetella pertussis organisms 
(Department of Public Health, Boston, Mass.). 
Fluorescent Staining.  1 ×  106 lymphocytes in "staining" medium (RPMI  1640, 0.1% NAN3, 
I0 mM Hepes,  1% fetal calf serum) were placed in wells in a 96-well microtiter plate, and 1/zl 
of fluorescein isothiocyanate (FITC)-conjugated antibody was added per well. After a 30-min 
incubation  on  ice,  cells  were  washed  once  with  staining  medium  and  analyzed  with  a 
fluorescence-activated cell sorter (FACS-II, Becton, Dickinson FACS Systems, Mountain View, 
Calif.)  (19). For monoclonal rat anti-IgM and anti-ThB, a two-step staining protocol was used 
in which cells were incubated first with unconjugated antibody and the bound antibody then 
revealed by incubation with affinity-purified "conventional" FITC-conjugated mouse anti-rat 
Ig  (17).  All  staining  reagents  were  titrated  and  used  at  concentrations  slightly  above  the 
minimum amount of antibody required to reach "plateau" staining (where an increase in the 
antibody concentration does not increase the number of or the brightness of the stained cells). 
Peripheral  blood  lymphocytes were  prepared  by  taking  arterial  blood  (tail  artery)  into 
medium  (RPMI  1640) containing heparin  (10 U/ml).  Live lymphocytes were separated  by 
centrifuging away dead cells and erythrocytes through a Ficoll layer (Lympholyte M; Accurate 
Chemical & Scientific Corp., Hicksville,  N. Y.) and recovering the cells that remained at the 
interface between the Ficoll and the original suspending medium. 
Quantitative Measurement of Serum Allotype Ig Levels.  Serum allotype levels were measured by 
a solid-phase "antibody consumption" radioimmunoassay (RIA), as previously described (20). 
Briefly,  dilutions of a  standard Ig (purified myeloma protein of the appropriate  allotype) or 
serum samples  from test  mice were  mixed with  l~SI-labeled antiallotype  antibody and  then 
placed in a microtiter plate well precoated with the myeloma protein used as the standard. The 
amount of allotype Ig in  the sample  is calculated  by comparing the amount of a2~I-labeled 
antibody whose binding is blocked by the sample with the amount of binding blocked by the 
purified myeloma protein standard. 
Measurement of Memory B  Cell Activity (Adoptive Secondary Assay).  Memory B  cell  activity 
generated in individual DNP-KLH-primed donors was measured by co-transferring T depleted 
B cells  (spleen  cells  treated  with  monoclonal rat  anti-Thy-l.2  and  guinea pig complement) 
from these donors with nylon-passed T cells from carrier (KLH)-primed donors and stimulating 
the irradiated recipient with 1/Lg  aqueous DNP-KLH. Each recipient was injected intravenously 
with  (T cell-depleted)  B ceils recovered from  107 spleen cells and 2.5  ×  l0  s carrier-primed T 
cells. Cell populations and DNP-KLH were mixed just before injection into X-irradiated (650 
rad,  18 h previously) BALB/c recipients. Anti-DNP antibody responses  of sera from recipients 
at 7 d after transfer were measured by solid-phase RIA. 
Measurement of IgG Anti-DNP  Responses.  The  solid-phase  RIA used  here  to  measure  the 
amounts of anti-DNP antibody carrying each of four IgG allotypes (la,  lb, 4a, and 4b) have 
been described previously (20, 21). 
Results 
IgD-bearing Cells Are Depleted in Neonates after Exposure to Anti-IgD Antibody.  Perinatal 
exposure to anti-Igh-5b (the paternal  IgD allotype in BALB/c ×  SJL mice) depletes 
B cells bearing the Igh-5b allotype (5b + cells)  from 3- to 5-wk-old mice (Fig.  1). The 
absolute frequency of IgD-bearing B cells in these animals  varies considerably, as it 
does in untreated  (control) mice; therefore, the ratio of 5a÷/5b + B cells in spleen or in 
peripheral  blood  lymphocytes  provides  a  better  index  of disturbances  in  the  5b  + 
population. This ratio always approximates  1 in control animals, regardless of the size 
of the B cell population or the age of the animals. In young anti-5b-exposed animals 
(3-5 wk of age), however, the 5a÷/5b + ratio rises substantially  above  1. Because the 
frequency of 5a  + cells is similar in control and anti-5b-exposed animals, this increased 
ratio indicates a  severe and specific depletion of the 5b  + population. 
The failure to detect 5b  ÷ B cells in the young anti-5b-exposed animals represents a TOKUHISA ET AL.  925 
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Fie.  1.  Perinatal  exposure to anti-5b specifically  deletes 5b  + cells for a prolonged period. Percent- 
age of 5a  + and percentage of 5b  ÷ cells in spleen cell preparations from individual animals injected 
with 250 #g anti-5b (A) or from littermate controls (A); Percentages  in peripheral blood lymphocytes 
from anti-5b-injected mice (0) and littermate (C)) controls. 
depletion of these cells rather than interference with detection of 5b determinants by 
the injected antibody or removal (stripping) of surface 5b from cells that nonetheless 
persist.  The  injected  monoclonal  antibody  (11-6.3)  reacts  with  different  allotype 
determinants than those detected by the monoclonal reagent  (H6/31)  used to stain 
5b-bearing B cells for FACS analysis and does not block staining by this reagent (data 
not shown). Furthermore, the anti-5b-exposed young animals do not have an excess 
of 5b-  cells  carrying  other  B  cell  surface  markers  normally  present  on  5b  +  cells. 
Instead, the splenic and peripheral blood lymphocytes taken from these animals show 
lower B cell frequencies consistent with  depletion  of the 5b  + population,  i.e.,  fewer 
/~+,ThB +  cells  than  the  unexposed  control  animals.  The  depleted  5b  +  population 
accounts for this reduction  in  the overall size of the B  cell population  because the 
non-5b  + B cell populations (5a  + plus ~t+,5a  -) are equivalent in size in anti-5b-treated 
and control animals (Fig. 2). 
Depleted IgD-bearing Populations Recover Gradually after Perinatal Exposure to Anti-IgD 
Antibodies.  As anti-5b-exposed mice age, they gradually develop a  5b  + B cell popu- 
lation  that  reaches  about  one-half its  normal  size  in  9-  to  16-wk old  animals  and 
becomes very close to normal in size in mice >38 wk of age (Fig.  1). Because the size 
of the B  cell population  ~+,ThB +)  increases concomitantly with the increase in the 
5b-bearing population  (Fig. 2), these data indicate the emergence of a  distinct  B cell 
population  (5b  ÷) that was absent in neonatal anti-5b-exposed mice. 
This overall trend toward recovery is more pronounced in some mice than in others. 
Examination  of the  5a/5b  ratio  in  individual  38-  to 40-wk-old  mice, for example, 
reveals a  few mice with apparently normal B cell populations  (5a/5b ~ 1)  and a  few 
mice in  which  B  cell  populations  are more like the  populations  in  9- to  16-wk-old 
mice (5a/5b -2). These mice represent the upper and lower extremes of a group that 
generally shows  5a/5b  ratios of-1.1-1.3  and  thus  come quite  close  to  normality; 
however,  sufficient  numbers  of mice  fall  towards  the  lower  extreme  to  indicate  a 
sizable variation in recovery rates. 
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paternal haplotype IgG production.  12-wk-old suppressed mice that have more than 
one-half their normal complement of 5b  ÷ cells frequently show maximally suppressed 
serum IgG allotype levels until  24 wk of age  (see  below).  Thus,  as in  the  allotype- 
suppressed  rabbit  (5-8),  the  reappearance  of the  depleted  B  cell  population  can 
substantially precede the onset of production of the suppressed serum Ig. 
Anti-IgD-induced Allotype Suppression Differs from Chronic Allotype Suppression.  Three 
properties distinguish the long-term suppression induced by anti-5b from the chronic 
allotype  suppression  induced  by  anti-lb  or  anti-IgM:  (a)  anti-5b-suppressed  mice 
recover the ability to produce paternal  haplotype serum  IgG by 24 wk of age and 
subsequently  maintain  this  ability,  whereas  anti-lb-suppressed  mice  recover  tran- 
siently between  12 and  20 wk of age but  typically develop a  persistent  suppression 
after 20-24  wk of age;  (b)  paternal allotype serum levels seldom  fall below  10%  of 
control  levels  in  anti-5b-suppressed  mice,  whereas  serum  lb  levels  in  chronically 
suppressed mice are typically lower than  l a and then maintain < 1% of control levels 
during  the  initial  and  terminal  phases  of suppression;  and  (c)  maternal  haplotype 
serum IgG levels rise to "compensate" for the reduced paternal haplotype IgG levels 
in anti-5b-suppressed mice but remain at control levels in anti-lb-suppressed animals 
(Figs. 3 and 4). 
Anti-IgD-induced Suppression Interferes with Memory B Cell Development.  The production 
of paternal allotype anti-DNP antibodies is suppressed when serum allotype produc- 
tion is suppressed in both anti-lb (19,  20)  and anti-5b- (chronic) suppressed animals 
(Fig. 5). Furthermore, the ability to produce these allotype-marked antibody responses 
recovers in both types of animals whenever serum allotype production recovers, i.e., 
in older anti-5b-exposed animals and in anti-lb-exposed animals during the "remis- 
sion" period that occurs between 12 and 20 wk of age. Thus, both types of suppression 
have similar effects on in situ antibody responses. 
Analysis of the memory B cell populations induced when animals are primed while TOKUHISA ET AL.  927 
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suppressed, however, demonstrates a  marked distinction  between chronic and  anti- 
5b-induced suppressions. Chronic suppression interferes with the later stages of B cell 
memory development (IgD  + to IgD- transition)  but does not reduce the overall size 
of the  memory population  (21).  Anti-5b-induced  suppression,  in  contrast,  clearly 
reduces the size (or effectiveness) of the paternal haplotype memory B cell population 
capable of generating adoptive secondary responses (Table II). 
This reduction  can be seen clearly by comparing the a  and b  allotype responses 
obtained from cells derived from individual, suppressed donors of each type. Adoptive 
secondary  anti-DNP  responses  from T  cell-depleted  spleen  cell  populations  taken 
from individual DNP-primed donors and supplemented with the same carrier-primed 
T  cell population often vary over a three- or fourfold range; however, the ratio of the 
allotypes represented in adoptive responses from allotype heterozygous donors tends 928  NEW TYPE OF INDUCED ALL•TYPE SUPPRESSION  IN THE MOUSE 
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to deviate only slightly from 1 (-  20-30%)  regardless of the overall magnitude of the 
adoptive  response.  Thus,  it  provides  a  reliable  index  of perturbations  in  memory 
development  independent  of factors that  influence the overall size or activity of the 
memory pool. 
This ratio reveals a striking difference when memory B cell responses from normal 
or chronically suppressed donors primed at  12 wk of age are contrasted with memory 
B cell responses from similarly primed anti-5b-suppressed  animals.  The B  cells from 
normal and chronically suppressed donors give rise to comparable a and b haplotype 
adoptive  responses  indicative  of the  absence  of interference  with  overall  memory 
development in the chronically suppressed mice. The B cells from anti-5b-suppressed 
mice,  however,  give  rise  to  responses  that  are  heavily  weighted  in  favor  of the  a 
allotype. 
The increased  a:b allotype ratios  in  these  animals  appear  mainly  to be  due  to a 
reduction in the size of the b allotype memory B cell population because the a allotype 
responses fall within normal range, whereas the b  allotype responses are clearly lower TOKUHISA ET  AL.  929 
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FIG.  5.  Suppression  of lb antibody production induced by perinatal exposure  to anti-5b. Anti-5b- 
exposed  (0) and littermate control (©) animals were primed with 100/zg DNP-KLH on alum at the 
indicated  time;  serum  antibody  levels  in  individual  mice, measured  by  RIA  2  wk  later,  are 
representative of levels measured 1-6 wk after priming. (See Figs. 3 and 4 for time-course of anti-5b- 
induced suppression) 
TABLE  II 
Perinatal Anti-5b Exposure Interferes with b Haplotype Memory B Cell Development in Adults 
Anti-DNP response:~ 
Anti-DNP* mem-  Donor 
ory B cell donors  Number  IgG2.  IgG1 
Igh- la  Igh- lb  I a/I b  Igh-4a  Igh-4b  4a/4b 
Anti-5b injected 
#g/ml 
1  36  17  (2.1)  105  15  (7.0) 
2  72  22  (3.3)  135  15  (9.0) 
3  126  30  (4.2)  210  80  (2.6) 
Anti- lb§ exposed  4  89  73  (1.2)  320  275  (1.2) 
5  78  58  (1.3)  225  250  (0.9) 
6  47  46  (1.0)  238  250  (1.0) 
7  108  99  (1.1)  230  255  (0.9) 
8  83  94  (0.9)  150  175  (0.9) 
Uninjected control 
*  BALB/c × SJL mice were primed with DNP-KLH at 8 wk of age. 4 wk later, T cell-depleted spleen cells 
(5 X  10  n) were supplemented with 2.5 ×  106 KLH-primed nylon-purified T cells and transferred with 1 
pg of DNP-KLH into irradiated BALB/c mice. 
:1: Antibodies in serum measured by RIA at 6 d after transfer. 
§  BALB/c ×  SJL mice exposed  perinatally to maternal anti-Igh-lb. 
than  normal;  however,  we  have  not  tested  a  large  enough  number  of animals  to 
exclude  the occurrence of some compensatory  development  of maternal  (a)  allotype 
memory.  Thus,  although  some  memory  development  is  permitted  in  anti-5b-sup- 
pressed mice, the suppression  definitely interferes with the normal pattern  of memory 
B  cell development. 
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number of 5b ÷ B cells, but this deficit cannot solely explain the deficit in b allotype 
memory. The ratios of 5a+:5b ÷ ceils were not  measured for the donors used in this 
experiment; however, these ratios are usually around 2, whereas the a:b allotype ratio 
in the IgG adoptive response generated by the memory B cells from the suppressed 
animals ranges from 2.1-9. This suggests either that the missing 5b  + ceils constitute 
a subpopulation that selectively gives rise to memory B cells or that the mechanisms 
through which the suppression interferes with memory development are independent 
of the size of the 5b  ÷ populations. The recovery of normal memory development in 
38-wk-old  anti-5b-exposed mice  (data  not  shown)  is  consistent  with  both  of these 
hypotheses and further documents the relatively complete recovery from suppression 
in these mice. 
Different  Mechanisms  Are  Involved  in  Chronic  and  Anti-lgD-induced  Allotype 
Suppression.  The failure to induce chronic suppression by perinatal anti-5b exposure 
cannot be merely the result of exposure to suboptimum doses of anti-5b.  Increasing 
the dose of anti-5b by injecting three sequential 250/zg doses of antibody at 4, 7, and 
11 d of age (total 750/.tg/mouse) or injecting anti-5b within a few hours of birth does 
not alter the typical suppression pattern obtained with this antibody (data not shown). 
Chronic suppression, however, can be induced by 125-250/xg of monoclonal anti-lb 
administered as late as 17 d after birth (18). In addition, although aUotype suppressor 
T  cells  are  readily  detectable  in  young as  well  as  in  older  anti-lb-  or  anti-IgM- 
suppressed mice (3, 4,  11,  18, 22), lymphocyte populations from anti-5b-suppressed 
mice show no suppressive activity when tested in the same kinds of assays (data not 
shown). Thus, the differences between chronic and anti-5b-induced allotype suppres- 
sion must represent fundmental mechanistic differences occasioned by the induction 
of suppression with antibodies to different immunoglobulins. 
We have suggested that anti-IgM or anti-lb exposures temporarily deplete neonatal 
B  cell populations required to prevent the induction of atlotype suppressor T  cells 
and consequently to prevent the induction of  chronic suppression (I0). Data presented 
here showing that anti-5b depletes virtually all 5b  + cells from the neonate but does 
not induce chronic suppression indicates either that this suggestion is incorrect or that 
the  relevant B  cell population in  newborn and  neonatal animals  does not  carry a 
sufficient amount of surface 5b (IgD) to permit its depletion. 
Discussion 
The prolonged suppression of IgG production that occurs in BALB/c ×  SJL mice 
after exposure to anti-Ig antibodies during the first few weeks of life dramatizes the 
importance of the neonatal period in establishing the immunologic behavior of the 
animal. Perinatal exposure to anti-Igh-lb  (anti-lb)  or anti-IgM antibodies results in 
a  lifelong  suppression  of  lb  production  because  of the  neonatal  induction  of a 
persistent population of allotype-suppressor T  cells (4,  10,  11). Similarly, as we have 
shown here, perinatal exposure to anti-IgD  (5b)  allotype antibodies induces a  long- 
term suppression of paternal allotype IgG production that compromises the animal 
vis-fi-vis antibody production until -6 mo of age. The mechanisms responsible for the 
induction  and  for the  differences between  these  two  types  of suppression  are  still 
obscure; however, their existence clearly demonstrates that alterations in the neonatal 
immune  system  occasion  immunoregulatory  deviations  manifested  many  months 
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The curious coincidence between the time the chronic suppression mechanism tends 
to reassert control over antibody production and  the time that  anti-5b suppression 
tends  to  be  relieved suggests  that  the  immune  system  undergoes  a  "pleiotropic" 
change late in the life of the animal  (~5-6 mo of age in the mouse). Several other 
kinds of immunoregulatory abnormalities also show a tendency to initiate or exacer- 
bate at this time. For example, high levels of autoantibodies tend to appear in certain 
mouse strains (23) and IgG paraproteins are frequently detected in others (particularly 
SJL)  (24).  Taken  together,  these  findings  raise  the  possibility  that  older  adults 
normally develop a qualitatively different set of regulatory mechanisms whose behav- 
ior is  determined  in  part  by genetic elements and  in  part  by individual  perinatal 
experience. 
The BALB/c X  SJL mice used in many of our studies, including those presented 
here, have a genetic defect that renders them sensitive to chronic suppression induction 
when exposed perinatally to anti-lb or anti-IgM  (10). We have shown earlier (11) 
that  this  suppression  is  induced  in  the  presence  of  maternally  derived  anti-5b 
antibodies  in  animals  exposed  to  a  mixture  of maternal  antibodies  reactive with 
paternal  allotypes on IgM and  IgD, and we have shown here that the suppression 
induced by anti-5b differs substantially from chronic suppression. Thus, because anti- 
5b neither induces nor interferes with the induction of chronic suppression, the genetic 
defect responsible for the induction and/or maintenance of this suppression apparently 
involves processes independent of the mechanisms that induce and maintain the anti- 
5b-induced suppression. 
We have not  investigated the effects of anti-5b  exposure in other mouse strains. 
Studies from other laboratories (25), however, suggest that  the suppression induced 
by this antibody in BALB/c ×  SJL is probably representative of anti-IgD-induced 
suppression  in  general. The similarities  between  the  anti-5b-induced allotype sup- 
pression in mice and the typical allotype suppression observed in rabbits  (5-8)  also 
suggests a common mechanism. Further study, however, is clearly required to establish 
this point and to develop some ideas as to what the nature of such a mechanism could 
be. 
In a sense, our findings are a new addition to the already puzzling array of data on 
immunoregulatory  processes.  We  have  shown  clearly  that  perinatal  exposure  to 
antibodies  reactive  with  paternal  IgD  (Igh-5b)  allotypic  determinants  induces  a 
unique form of allotype suppression characterized by (a) the initial depletion of the 
B  cell  population  that  carries  this  IgD  allotype;  (b)  the  gradual  increase  of this 
population with age; (c) the interference with paternal haplotype IgG memory B cell 
development; (at) the suppression of paternal allotype IgG production even after the 
depleted  B  cell  populations  have  substantially  recovered;  (e)  the  compensatory 
production of maternal IgG allotype production; and (f) the eventual recovery of all 
affected functions late in life. 
We  wonder,  for  example,  whether  neonatal  B  cell  populations  may  be  more 
complex than were previously imagined.  Is it possible that  the small percentage of 
IgM+,IgG + B  cells seen shortly after birth  (26)  represents a  different B cell lineage 
rather than early-emerging precursors of the IgM+,IgD  + population that  appears a 
few days later? Could these cells perhaps be a regulatory population? Are they related 
to the Lyt-l-bearing B cells apparently present in splenic B cell areas in the adult?  2 
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Does their depletion in the neonate permit the induction of chronic allotype suppres- 
sion (if such suppression is due to B cell depletion)? 
Considering  the  adult,  one might  ask why the  5b  ÷  population  takes  so  long to 
recover after perinatal depletion. The rapid turn-over of "virgin" B lymphocytes in 
young adults  would  predict  that  a  depleted population would be rapidly replaced 
once the depleting agent disappears, yet anti-Sb-treated mice take months to recover 
a normal-sized 5b  + population. Could there be homeostatic mechanisms that fix the 
size  of this  population  in  adults  according  to  its  size  in  the  neonate?  Do  these 
homeostatic mechanisms lose force as the animal ages? 
The reader can undoubtedly extend this list; however, for the moment it serves its 
purpose  by  pointing  out  the  kinds  of basic  information  still  required  before  an 
understanding of the complex processes involved in suppression induction is likely to 
emerge. At a minimum, the findings presented here clearly indicate that current views 
of B  cell  development  regulatory  T  cell  interactions  will  have  to  be  revised  or 
expanded to account for the distinctive patterns of suppression induced by antibodies 
to the two cell surface immunoglobulins present on the majority of neonatal and adult 
B cells. 
Summary 
Studies presented here show that perinatal exposure to anti-IgD allotype antibodies 
induces a persistant IgG-allotype suppression in the mouse that differs markedly from 
either the short-term or chronic allotype suppressions induced by antibodies to IgG or 
IgM allotypes. This novel form of aUotype suppression induced by injecting neonatal 
BALB/c ×  SJL mice with monoclonal antibody to the paternal Igh-5b (IgD) allotype 
drastically reduces paternal allotype production during the first 6 mo of the affected 
animal's  life and  simultaneously  stimulates  compensatory production  of maternal 
allotype IgG. In addition, it interferes with the development of B cells carrying the 
paternal  IgD allotype and  impairs the development of memory B  cells destined to 
give rise to paternal allotype IgG-producing cells.  Thus, its properties make it more 
like  allotype suppression  as  described  in  the  rabbit  than  like  the  known  forms of 
allotype suppression in the mouse. 
As  shown  here,  Igh-5b-bearing  (5b  +)  B  cells  are  completely depleted  from  the 
neonate after anti-5b exposure and only gradually appear as the animal  ages. The 
recovery of the 5b + population to near normal size (by -14 wk of age) substantially 
preceeds recovery of the ability to generate normal-sized memory B cell populations. 
Paternal allotype levels in serum remain well below normal until the anti-5b-exposed 
animals  reach  -6  mo  of age  and  then  climb  rapidly,  finally stabilizing  at  levels 
comparable to levels in controls of the same age. The elevated maternal allotype levels 
characteristic of the suppression period begin falling somewhat earlier and are clearly 
stabilized within the normal range in 6-too-old animals. Thus, perinatal exposure to 
anti-5b  compromises  B  cell  development  and  IgG  production  throughout  early 
adulthood but has little apparent effect in older animals. 
Perinatal  exposure to  antibody to  the  paternal  IgG2a  allotype (Igh-lb)  or IgM 
allotype (Igh-6b), in contrast, induces a chronic allotype suppression that has relatively 
little  affect  on  IgG  production  in  young  adults  but  severely  suppresses  allotype 
production in older animals. Furthermore, this type of (chronic) suppression does not 
influence maternal  allotype production and  does not  interfere with memory B  cell TOKUHISA ET AL.  933 
development.  These differences, illustrated  here by data from parallel sets of animals 
exposed either  to anti-5b or anti-lb,  raise a  series of intriguing  questions  concerning 
the mechanisms regulating  B cell development  and expression and the nature of the 
neonatal  (B) cell populations  with which  the suppression-inducing  antibodies react. 
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